BUY Pfizer (PFE).

Ken Fisher, Fisher Investments

Says Fisher of the
pharma stalwart, “It has near endless top-notch brand names, and a stream of
new products will capture growth from an aging developed-world demographic plus
new emerging middle classes overseas—all wrapped in a classically cheap stock.”